GENOMICS ENGLAND LIMITED

Company number 08493132

Date	Type	Description	View / Download
17 Apr 2024	CS01	Confirmation statement made on 17 April 2024 with updates	(4 pages)
20 Mar 2024	AP01	Appointment of Dr Douglas John Gurr as a director on 20 March 2024	(2 pages)
31 Jan 2024	TM01	Termination of appointment of Andrew Eland as a director on 25 January 2024	(1 page)
22 Jan 2024	AP01	Appointment of Mr Richard Henry Meddings as a director on 4 December 2023	(2 pages)
05 Dec 2023	SH01	Statement of capital following an allotment of shares on 4 December 2023 GBP 587,700,001	(3 pages)
01 Nov 2023	TM01	Termination of appointment of Christopher Martin Wigley as a director on 31 October 2023	(1 page)
01 Nov 2023	TM01	Termination of appointment of Timothy Gregg Ferris as a director on 31 October 2023	(1 page)
11 Sep 2023	AP01	Appointment of Dr Richard Hywel Scott as a director on 4 September 2023	(2 pages)
02 Aug 2023	AA	Full accounts made up to 31 March 2023	(39 pages)
17 May 2023	SH01	Statement of capital following an allotment of shares on 15 May 2023 GBP 550,200,001	(3 pages)
27 Apr 2023	CS01	Confirmation statement made on 17 April 2023 with updates	(4 pages)
19 Apr 2023	AD02	Register inspection address has been changed from Dawson Hall Charterhouse Square London EC1M 6BQ England to Level 21 One Canada Square London E14 5AB	(1 page)
08 Feb 2023	SH01	Statement of capital following an allotment of shares on 30 January 2023 GBP 500,200,001	(3 pages)
20 Dec 2022	AD01	Registered office address changed from One Canada Square Canada Square London E14 5AB England to Level 21 One Canada Square Canada Square London E14 5AB on 20 December 2022	(1 page)
20 Dec 2022	AD01	Registered office address changed from Dawson Hall Charterhouse Square London EC1M 6BQ to One Canada Square Canada Square London E14 5AB on 20 December 2022	(1 page)
10 Nov 2022	SH01	Statement of capital following an allotment of shares on 23 September 2022 GBP 470,200,001	(3 pages)
10 Nov 2022	AP01	Appointment of Dr Timothy Gregg Ferris as a director on 12 September 2022	(2 pages)
17 Aug 2022	AA	Full accounts made up to 31 March 2022	(32 pages)
15 Aug 2022	AP01	Appointment of Nicola May Roche Perrin as a director on 18 July 2022	(2 pages)
08 Aug 2022	TM01	Termination of appointment of Michael John Parker as a director on 31 July 2022	(1 page)
11 Jul 2022	CH01	Director's details changed for Mr Jonathan Richard Symonds on 30 December 2019	(2 pages)
16 May 2022	RP04CS01	Second filing of Confirmation Statement dated 20 April 2022	(3 pages)
13 May 2022	SH01	Statement of capital following an allotment of shares on 15 November 2021 GBP 440,200,001	(3 pages)
28 Apr 2022	SH01	Statement of capital following an allotment of shares on 25 April 2022 GBP 410,200,001	(3 pages)
20 Apr 2022	CS01	Confirmation statement made on 17 April 2022 with updates ANNOTATION Clarification a second filed CS01 (shareholders) was registered on 16/05/22	(5 pages)